Short Duration Levetiracetam to Extended Course for Seizure Prophylaxis After aSAH

Completed · Not applicable

Conditions studied: Subarachnoid Hemorrhage

In brief

Our primary objective is to compare two treatment options for prevention of seizures following a subarachnoid hemorrhage and determine if a short-course regimen of levetiracetam is as efficacious in the prevention of in-hospital seizures when compared to an extended course.

Key facts

Study ID

NCT01137110

Run by

Washington University School of Medicine

People needed

84

Starts

2010-05-01

Expected to finish

2017-01-01

Last updated by the study team

2019-07-12

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age >18 years of age
• Diagnosis of spontaneous SAH

You may not qualify if…

• SAH secondary to trauma or arteriovenous malformation
• Early death (defined as death within 3 days of presentation)
• Known allergy to levetiracetam
• Know seizure history on chronic AEDs
• Pregnancy
• Current incarceration

Where it is running

• Barnes-jewish Hospital — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.